🇧🇪 Belgium Country × Condition
systemic lupus erythematosus Clinical Trials in Belgium
Active clinical trials for systemic lupus erythematosus with research sites in Belgium. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 3 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇧🇪 Belgium
Active Trials in Belgium (2)
NCT07201558 Phase 1
Recruiting
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Enrollment
48 pts
Country
🇧🇪 Belgium
AstraZeneca
View Trial → NCT06617325 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Enrollment
450 pts
Country
🇧🇪 Belgium
UCB Biopharma SRL
View Trial → Frequently Asked Questions
How many systemic lupus erythematosus clinical trials are active in Belgium?
There are currently 2 active clinical trials for systemic lupus erythematosus with sites in Belgium, of which 2 are actively recruiting patients.
How can I join a systemic lupus erythematosus clinical trial in Belgium?
To join a systemic lupus erythematosus clinical trial in Belgium, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Belgium directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are systemic lupus erythematosus trials in Belgium?
Active systemic lupus erythematosus trials in Belgium span Phase 1, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology